Search for: "Pfizer Pharmaceuticals, LLC"
Results 1 - 20
of 156
Sorted by Relevance
|
Sort by Date
5 May 2020, 9:37 pm
Noonan -- The Federal Circuit continued its explication of the standing issue for unsuccessful petitioners in inter partes review (see "Argentum Pharmaceuticals LLC v. [read post]
28 Apr 2016, 2:39 pm
Pursuant… The post Pharmaceutical Giant Pfizer, Inc. [read post]
15 Oct 2021, 2:00 am
In 2012, Harrison Realty, LLC. purchased Pfizer’s Brooklyn real estate for $12,750,000. [read post]
28 Apr 2016, 11:09 am
The post Pharmaceutical Giant Pfizer, Inc. [read post]
24 Jun 2015, 9:59 pm
Teva Pharmaceuticals USA, Inc. [read post]
2 May 2010, 9:52 pm
Watson Pharmaceuticals, Inc. et al. 0:10-cv-60674; filed April 29, 2010 in the Southern District of Florida • Plaintiffs: Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc. [read post]
28 Feb 2015, 4:26 am
Australia’s competition watchdog has failed to convince a Federal Court judge that a strategy employed by pharmaceutical company Pfizer, to enter the market for generic products upon expiry of its patent covering blockbuster cholesterol-lowering drug LIPITOR, constituted an illegal misuse of market power, or ‘exclusive dealing’: Australian Competition and Consumer Commission v Pfizer Australia Pty Ltd [2015] FCA 113.From the year 2000, when it acquired… [read post]
29 Sep 2013, 9:11 pm
Apotex Inc. et al. 1:13-cv-01613; filed September 25, 2013 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings LLC • Defendants: Apotex Inc.; Apotex Corp. [read post]
11 Jan 2015, 9:59 pm
Mylan Inc. et al. 1:15-cv-00026; filed January 8, 2015 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings LLC • Defendants: Mylan Inc.; Agila Specialties Private Ltd.; Mylan Pharmaceuticals Inc. [read post]
7 Aug 2012, 12:54 pm
The SEC filed a separate Complaint charging another pharmaceutical company that Pfizer acquired several years ago – Wyeth LLC – with its own FCPA violations. [read post]
9 Oct 2011, 9:37 pm
Watson Pharmaceuticals Inc. et al. 1:11-cv-00914; filed October 6, 2011 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Alpharma Pharmaceuticals LLC; King Pharmaceuticals Inc. [read post]
7 Dec 2009, 8:37 pm
Kremers Urban LLC et al. 1:09-cv-00924; filed December 3, 2009 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Pfizer Ireland Pharmaceuticals; Warner-Lambert Co.; Warner-Lambert Co. [read post]
11 Dec 2011, 6:14 pm
LLC; C P Pharmaceuticals International CV; Northwestern University • Defendants: Alembic Ltd.; Alembic Pharmaceuticals Ltd. [read post]
9 Aug 2012, 11:29 am
The SEC separately charged another pharmaceutical company that Pfizer acquired in 2009, Wyeth LLC, with additional FCPA violations.Pfizer and Wyeth agreed to separate settlements in which they will pay more than $45 million combined to settle their respective charges. [read post]
7 Aug 2012, 10:11 am
The SEC separately charged Wyeth LLC—Pfizer purchased the company in 2009—with violations of the Foreign Corrupt Practices Act. [read post]
15 Aug 2010, 9:00 pm
Actavis Group Hf et al. 1:10-cv-00675; filed August 11, 2010 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Pfizer Ireland Pharmaceuticals; Warner Lambert Co.; Warner Lambert Co. [read post]
26 Jun 2013, 6:30 am
Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. [read post]
20 Jun 2010, 8:51 pm
LLC; Sugen Inc.; C P Pharmaceuticals International CV • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
25 Jan 2009, 2:36 pm
" Pfizer's acquisition of Madison, New Jersey-based Wyeth, if approved, would be the largest in almost five years in the pharmaceutical industry. [read post]
